{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:41:20Z","timestamp":1791013280021,"version":"4.1.0"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03461-z","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T20:56:17Z","timestamp":1779915377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring Synergistic Potential of Sorafenib and Atorvastatin to Launch Apoptosis and Ferroptosis-driven Mixed Cell Death Mechanism in Colorectal Cancer"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8957-8875","authenticated-orcid":false,"given":"Vivek","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6375-1256","authenticated-orcid":false,"given":"Sayali","family":"Dighe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5435-8807","authenticated-orcid":false,"given":"Pratik","family":"Dhake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0688-9563","authenticated-orcid":false,"given":"Sanyog","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"issue":"5","key":"3461_CR1","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.ajps.2022.07.006","volume":"17","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Ji Y, Hu N, Yu Q, Zhang X, Li J, et al. Ferroptosis-induced anticancer effect of resveratrol with a biomimetic nano-delivery system in colorectal cancer treatment. Asian J Pharm Sci. 2022;17(5):751\u201366. https:\/\/doi.org\/10.1016\/j.ajps.2022.07.006.","journal-title":"Asian J Pharm Sci"},{"issue":"1","key":"3461_CR2","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/imr.12533","volume":"277","author":"SJ Dixon","year":"2017","unstructured":"Dixon SJ. Ferroptosis: bug or feature? Immunol Rev. 2017;277(1):150\u20137. https:\/\/doi.org\/10.1111\/imr.12533.","journal-title":"Immunol Rev"},{"key":"3461_CR3","doi-asserted-by":"crossref","unstructured":"Wu H, Wang Y, Tong L, Yan H, Sun Z. Global Research Trends of Ferroptosis: A Rapidly Evolving Field With Enormous Potential. Frontiers in Cell and Developmental Biology [Internet]. 2021 [cited 2023 May 9];9. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.646311.","DOI":"10.3389\/fcell.2021.646311"},{"issue":"21","key":"3461_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15215209","volume":"15","author":"X Cheng","year":"2023","unstructured":"Cheng X, Zhao F, Ke B, Chen D, Liu F. Harnessing ferroptosis to overcome drug resistance in colorectal cancer: promising therapeutic approaches. Cancers Basel. 2023;15(21):5209. https:\/\/doi.org\/10.3390\/cancers15215209.","journal-title":"Cancers Basel"},{"issue":"3","key":"3461_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.tcb.2022.11.003","volume":"33","author":"H Yan","year":"2023","unstructured":"Yan H, Talty R, Johnson CH. Targeting ferroptosis to treat colorectal cancer. Trends Cell Biol. 2023;33(3):185\u20138. https:\/\/doi.org\/10.1016\/j.tcb.2022.11.003.","journal-title":"Trends Cell Biol"},{"issue":"8","key":"3461_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12080745","volume":"12","author":"X Liang","year":"2022","unstructured":"Liang X, You Z, Chen X, Li J. Targeting ferroptosis in colorectal cancer. Metabolites. 2022;12(8):745. https:\/\/doi.org\/10.3390\/metabo12080745.","journal-title":"Metabolites"},{"key":"3461_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123570","volume":"648","author":"R Ghadi","year":"2023","unstructured":"Ghadi R, Pandey PK, Gabhale A, Wadikar A, Dharshini M, Kuche K, et al. Genipin-crosslinked albumin nanoparticles containing neratinib and silibinin: a dual-death therapy for triple negative breast cancer. Int J Pharm. 2023;648:123570. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123570.","journal-title":"Int J Pharm"},{"key":"3461_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105998","volume":"100","author":"PK Pandey","year":"2024","unstructured":"Pandey PK, Bhorkade S, Jha S, Saren BN, Kuche K, Jain S. Ferroptosis: molecular perspective, cellular influence, cancer manifestation, and therapeutic potentials. J Drug Deliv Sci Technol. 2024;100:105998. https:\/\/doi.org\/10.1016\/j.jddst.2024.105998.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"3461_CR9","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1021\/acsnano.2c08706","volume":"17","author":"NT Nguyen","year":"2023","unstructured":"Nguyen NT, Kim J, Le XT, Lee WT, Lee ES, Oh KT, et al. Amplified Fenton-based oxidative stress utilizing ultraviolet upconversion luminescence-fueled nanoreactors for apoptosis-strengthened ferroptosis anticancer therapy. ACS Nano. 2023;17(1):382\u2013401. https:\/\/doi.org\/10.1021\/acsnano.2c08706.","journal-title":"ACS Nano"},{"issue":"36","key":"3461_CR10","doi-asserted-by":"publisher","first-page":"15105","DOI":"10.1074\/jbc.M117.783175","volume":"292","author":"C Zhang","year":"2017","unstructured":"Zhang C, Liu Z, Bunker E, Ramirez A, Lee S, Peng Y, et al. Sorafenib targets the mitochondrial electron transport chain complexes and ATP synthase to activate the PINK1\u2013Parkin pathway and modulate cellular drug response. J Biol Chem. 2017;292(36):15105\u201320. https:\/\/doi.org\/10.1074\/jbc.M117.783175.","journal-title":"J Biol Chem"},{"key":"3461_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.905947","volume":"13","author":"D Liao","year":"2022","unstructured":"Liao D, Yu L, Shangguan D, Zhang Y, Xiao B, Liu N, et al. Recent advancements of monotherapy, combination, and sequential treatment of EGFR\/ALK-TKIs and ICIs in non\u2013small cell lung cancer. Front Pharmacol. 2022;13:905947. https:\/\/doi.org\/10.3389\/fphar.2022.905947.","journal-title":"Front Pharmacol"},{"issue":"8","key":"3461_CR12","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1111\/cas.14493","volume":"111","author":"P Nguyen","year":"2020","unstructured":"Nguyen P, Chang C, Galvin CJ, Wang Y, An SY, Huang C, et al. Statins use and its impact in EGFR-TKIs resistance to prolong the survival of lung cancer patients: a cancer registry cohort study in Taiwan. Cancer Sci. 2020;111(8):2965\u201373. https:\/\/doi.org\/10.1111\/cas.14493.","journal-title":"Cancer Sci"},{"issue":"8","key":"3461_CR13","doi-asserted-by":"publisher","first-page":"5801","DOI":"10.1007\/s13277-015-3249-x","volume":"36","author":"O Fiala","year":"2015","unstructured":"Fiala O, Pesek M, Finek J, Minarik M, Benesova L, Bortlicek Z, et al. Statins augment efficacy of EGFR-TKIs in patients with advanced-stage non-small cell lung cancer harbouring KRAS mutation. Tumor Biol. 2015;36(8):5801\u20135. https:\/\/doi.org\/10.1007\/s13277-015-3249-x.","journal-title":"Tumor Biol"},{"issue":"12","key":"3461_CR14","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/nrc1751","volume":"5","author":"MF Demierre","year":"2005","unstructured":"Demierre MF, Higgins PDR, Gruber SB, Hawk E, Lippman SM. Statins and cancer prevention. Nat Rev Cancer. 2005;5(12):930\u201342. https:\/\/doi.org\/10.1038\/nrc1751.","journal-title":"Nat Rev Cancer"},{"issue":"21","key":"3461_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13215543","volume":"13","author":"HJ Jang","year":"2021","unstructured":"Jang HJ, Woo YM, Naka K, Park JH, Han HJ, Kim HJ, et al. Statins enhance the molecular response in chronic myeloid leukemia when combined with tyrosine kinase inhibitors. Cancers Basel. 2021;13(21):5543. https:\/\/doi.org\/10.3390\/cancers13215543.","journal-title":"Cancers Basel"},{"key":"3461_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.806081","volume":"10","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Qu H, Chen Y, Luo X, Chen C, Xiao B, et al. Atorvastatin induces mitochondria-dependent ferroptosis via the modulation of Nrf2-xCT\/GPx4 axis. Front Cell Dev Biol. 2022;10:806081. https:\/\/doi.org\/10.3389\/fcell.2022.806081.","journal-title":"Front Cell Dev Biol"},{"issue":"7784","key":"3461_CR17","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575(7784):688\u201392.","journal-title":"Nature"},{"issue":"7","key":"3461_CR18","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-023-02639-z","volume":"24","author":"K Kuche","year":"2023","unstructured":"Kuche K, Yadav V, Patel M, Ghadi R, Jain S. Exploring Sorafenib and Simvastatin combination for ferroptosis-induced cancer treatment: cytotoxicity screening, in vivo efficacy, and safety assessment. AAPS PharmSciTech. 2023;24(7):180. https:\/\/doi.org\/10.1208\/s12249-023-02639-z.","journal-title":"AAPS PharmSciTech"},{"key":"3461_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","volume":"22","author":"TC Chou","year":"1984","unstructured":"Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 1984;22:27\u201355.","journal-title":"Adv Enzyme Regul"},{"key":"3461_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s11051-019-4587-1","author":"S \u0141ukasiewicz","year":"2019","unstructured":"\u0141ukasiewicz S, Miko\u0142ajczyk A, Szcz\u0119ch M, Szczepanowicz K, Warszy\u0144ski P, Dziedzicka-Wasylewska M. Encapsulation of clozapine into polycaprolactone nanoparticles as a promising strategy of the novel nanoformulation of the active compound. J Nanopart Res. 2019. https:\/\/doi.org\/10.1007\/s11051-019-4587-1.","journal-title":"J Nanopart Res"},{"issue":"5","key":"3461_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03718-4","volume":"12","author":"Q Wang","year":"2021","unstructured":"Wang Q, Bin C, Xue Q, Gao Q, Huang A, Wang K, et al. GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2\/GPX4 axis. Cell Death Dis. 2021;12(5):5. https:\/\/doi.org\/10.1038\/s41419-021-03718-4.","journal-title":"Cell Death Dis"},{"issue":"6","key":"3461_CR22","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1021\/acsbiomaterials.1c01582","volume":"8","author":"T Date","year":"2022","unstructured":"Date T, Kuche K, Chaudhari D, Ghadi R, Sahel DK, Chitkara D, et al. Hitting multiple cellular targets in triple-negative breast cancer using dual-action Cisplatin(IV) prodrugs for safer synergistic chemotherapy. ACS Biomater Sci Eng. 2022;8(6):2349\u201362. https:\/\/doi.org\/10.1021\/acsbiomaterials.1c01582.","journal-title":"ACS Biomater Sci Eng"},{"key":"3461_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/srep20051","author":"MS Zaman","year":"2016","unstructured":"Zaman MS, Chauhan N, Yallapu MM, Gara RK, Maher DM, Kumari S, et al. Curcumin nanoformulation for cervical cancer treatment. Sci Rep. 2016. https:\/\/doi.org\/10.1038\/srep20051.","journal-title":"Sci Rep"},{"issue":"1","key":"3461_CR24","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s11605-016-3222-z","volume":"21","author":"S Setua","year":"2017","unstructured":"Setua S, Khan S, Yallapu MM, Behrman SW, Sikander M, Khan SS, et al. Restitution of tumor suppressor MicroRNA-145 using magnetic nanoformulation for pancreatic cancer therapy. J Gastrointest Surg. 2017;21(1):94\u2013105. https:\/\/doi.org\/10.1007\/s11605-016-3222-z.","journal-title":"J Gastrointest Surg"},{"key":"3461_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-023-04261-9","author":"P Panyajai","year":"2024","unstructured":"Panyajai P, Viriyaadhammaa N, Tima S, Chiampanichayakul S, Dejkriengkraikul P, Okonogi S, et al. Anticancer activity of Curcuma aeroginosa essential oil and its nano-formulations: cytotoxicity, apoptosis and cell migration effects. BMC Complement Med Ther. 2024. https:\/\/doi.org\/10.1186\/s12906-023-04261-9.","journal-title":"BMC Complement Med Ther"},{"key":"3461_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2024.213822","volume":"159","author":"R Ghadi","year":"2024","unstructured":"Ghadi R, Kuche K, Date T, Nallamothu B, Chaudhari D, Jain S. Unlocking apoptosis in triple negative breast cancer: harnessing \u201cglutamine trap\u201d to amplify the efficacy of Lapatinib-loaded mixed micelles. Biomaterials Advances. 2024;159:213822. https:\/\/doi.org\/10.1016\/j.bioadv.2024.213822.","journal-title":"Biomaterials Advances"},{"issue":"4","key":"3461_CR27","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1007\/s13346-022-01273-9","volume":"13","author":"D Chaudhari","year":"2023","unstructured":"Chaudhari D, Kuche K, Yadav V, Ghadi R, Date T, Bhargavi N, et al. Exploring paclitaxel-loaded adenosine-conjugated PEGylated PLGA nanoparticles for targeting triple-negative breast cancer. Drug Delivery and Translational Research. 2023;13(4):1074\u201387. https:\/\/doi.org\/10.1007\/s13346-022-01273-9.","journal-title":"Drug Delivery and Translational Research"},{"issue":"6","key":"3461_CR28","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1021\/acsbiomaterials.1c01582","volume":"8","author":"T Date","year":"2022","unstructured":"Date T, Kuche K, Chaudhari D, Ghadi R, Sahel DK, Chitkara D, et al. Hitting Multiple Cellular Targets in Triple-Negative Breast Cancer Using Dual-Action Cisplatin (IV) Prodrugs for Safer Synergistic Chemotherapy. ACS Biomaterials Science & Engineering. 2022;8(6):2349\u201362.","journal-title":"ACS Biomaterials Science & Engineering"},{"issue":"8","key":"3461_CR29","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1021\/acsbiomaterials.2c00594","volume":"8","author":"D Chaudhari","year":"2022","unstructured":"Chaudhari D, Katari O, Ghadi R, Kuche K, Date T, Bhargavi N, et al. Unfolding the Potency of Adenosine in Targeting Triple Negative Breast Cancer via Paclitaxel-Incorporated pH-Responsive Stealth Liposomes. ACS Biomaterials Science & Engineering. 2022;8(8):3473\u201384. https:\/\/doi.org\/10.1021\/acsbiomaterials.2c00594.","journal-title":"ACS Biomaterials Science & Engineering"},{"issue":"7","key":"3461_CR30","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1021\/acs.molpharmaceut.0c00211","volume":"17","author":"M Bathara","year":"2020","unstructured":"Bathara M, Date T, Chaudhari D, Ghadi R, Kuche K, Jain S. Exploring the promising potential of high permeation vesicle-mediated localized transdermal delivery of Docetaxel in breast cancer to overcome the limitations of systemic chemotherapy. Mol Pharm. 2020;17(7):2473\u201386.","journal-title":"Mol Pharm"},{"issue":"1","key":"3461_CR31","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1080\/10717544.2021.1979129","volume":"28","author":"T Zhong","year":"2021","unstructured":"Zhong T, Liu X, Li H, Zhang J. Co-delivery of sorafenib and crizotinib encapsulated with polymeric nanoparticles for the treatment of in vivo lung cancer animal model. Drug Delivery. 2021;28(1):2108\u201318. https:\/\/doi.org\/10.1080\/10717544.2021.1979129.","journal-title":"Drug Delivery"},{"issue":"12","key":"3461_CR32","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1016\/j.jsps.2020.11.012","volume":"28","author":"TM Faris","year":"2020","unstructured":"Faris TM, Harisa GI, Alanazi FK, Samy AM, Nasr FA. Developed Simvastatin chitosan nanoparticles co-crosslinked with tripolyphosphate and chondroitin sulfate for ASGPR-mediated targeted HCC delivery with enhanced oral bioavailability. Saudi Pharmaceutical Journal. 2020;28(12):1851\u201367. https:\/\/doi.org\/10.1016\/j.jsps.2020.11.012.","journal-title":"Saudi Pharmaceutical Journal"},{"key":"3461_CR33","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.synres.2018.04.001","volume":"7","author":"TC Chou","year":"2018","unstructured":"Chou TC. The combination index (CI < 1) as the definition of synergism and of synergy claims. Synergy. 2018;7:49\u201350. https:\/\/doi.org\/10.1016\/j.synres.2018.04.001.","journal-title":"Synergy"},{"issue":"3","key":"3461_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.synres.2016.06.001","volume":"3","author":"J Fu","year":"2016","unstructured":"Fu J, Zhang N, Chou JH, Dong HJ, Lin SF, Ulrich-Merzenich GS, et al. Drug combination in vivo using combination index method: Taxotere and T607 against colon carcinoma HCT-116 xenograft tumor in nude mice. Synergy Amst. 2016;3(3):15\u201330. https:\/\/doi.org\/10.1016\/j.synres.2016.06.001.","journal-title":"Synergy Amst"},{"key":"3461_CR35","unstructured":"Zhang N, Fu JN, Chou TC. Synergistic combination of microtubule targeting anticancer fludelone with cytoprotective panaxytriol derived from panax ginseng against MX-1 cells in vitro: experimental design and data analysis using the combination index method. Am J Cancer Res. 2015 Dec 15;6(1):97-104. PMID: 27073727; PMCID: PMC4759401."},{"issue":"6","key":"3461_CR36","doi-asserted-by":"publisher","first-page":"637","DOI":"10.4103\/0253-7613.194852","volume":"48","author":"S Kaushik","year":"2016","unstructured":"Kaushik S, Shyam H, Sharma R, Balapure A. Genistein synergizes Centchroman action in human breast cancer cells. Indian J Pharmacol. 2016;48(6):637. https:\/\/doi.org\/10.4103\/0253-7613.194852.","journal-title":"Indian J Pharmacol"},{"issue":"12","key":"3461_CR37","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.neo.2017.10.005","volume":"19","author":"S Hao","year":"2017","unstructured":"Hao S, Yu J, He W, Huang Q, Zhao Y, Liang B, et al. Cysteine dioxygenase 1 mediates Erastin-induced ferroptosis in human gastric cancer cells. Neoplasia. 2017;19(12):1022\u201332. https:\/\/doi.org\/10.1016\/j.neo.2017.10.005.","journal-title":"Neoplasia"},{"key":"3461_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1226044","volume":"11","author":"HT Endale","year":"2023","unstructured":"Endale HT, Tesfaye W, Mengstie TA. ROS induced lipid peroxidation and their role in ferroptosis. Front Cell Dev Biol. 2023;11:1226044. https:\/\/doi.org\/10.3389\/fcell.2023.1226044.","journal-title":"Front Cell Dev Biol"},{"issue":"42","key":"3461_CR39","doi-asserted-by":"publisher","first-page":"30452","DOI":"10.1074\/jbc.M703091200","volume":"282","author":"R Franco","year":"2007","unstructured":"Franco R, Panayiotidis MI, Cidlowski JA. Glutathione depletion is necessary for apoptosis in lymphoid cells independent of reactive oxygen species formation. J Biol Chem. 2007;282(42):30452\u201365. https:\/\/doi.org\/10.1074\/jbc.M703091200.","journal-title":"J Biol Chem"},{"issue":"2","key":"3461_CR40","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41401-020-0478-3","volume":"42","author":"Z Li","year":"2021","unstructured":"Li Z, Dai H, Huang X, Feng J, Deng J, Wang Z, et al. Artesunate synergizes with Sorafenib to induce ferroptosis in hepatocellular carcinoma. Acta Pharmacol Sin. 2021;42(2):301\u201310. https:\/\/doi.org\/10.1038\/s41401-020-0478-3.","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"3461_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05859-0","volume":"14","author":"S Zhang","year":"2023","unstructured":"Zhang S, Liu Q, Chang M, Pan Y, Yahaya BH, Liu Y, et al. Chemotherapy impairs ovarian function through excessive ROS-induced ferroptosis. Cell Death Dis. 2023;14(5):340. https:\/\/doi.org\/10.1038\/s41419-023-05859-0.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3461_CR42","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1021\/acsnano.2c08706","volume":"17","author":"NT Nguyen","year":"2023","unstructured":"Nguyen NT, Kim J, Le XT, Lee WT, Lee ES, Oh KT, et al. Amplified Fenton-based oxidative stress utilizing ultraviolet upconversion luminescence-fueled nanoreactors for apoptosis-strengthened ferroptosis anticancer therapy. ACS Nano. 2023;17(1):382\u2013401. https:\/\/doi.org\/10.1021\/acsnano.2c08706.","journal-title":"ACS Nano"},{"key":"3461_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/5080843","volume":"2019","author":"LJ Su","year":"2019","unstructured":"Su LJ, Zhang JH, Gomez H, Murugan R, Hong X, Xu D, et al. Reactive oxygen species-induced lipid peroxidation in apoptosis, autophagy, and ferroptosis. Oxid Med Cell Longev. 2019;2019:1\u201313. https:\/\/doi.org\/10.1155\/2019\/5080843.","journal-title":"Oxid Med Cell Longev"},{"issue":"10","key":"3461_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19103004","volume":"19","author":"K Lee","year":"2018","unstructured":"Lee K, Seo I, Choi MH, Jeong D. Roles of mitogen-activated protein kinases in osteoclast biology. Int J Mol Sci. 2018;19(10):3004. https:\/\/doi.org\/10.3390\/ijms19103004.","journal-title":"Int J Mol Sci"},{"key":"3461_CR45","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.semcdb.2023.07.003","volume":"156","author":"N Popgeorgiev","year":"2024","unstructured":"Popgeorgiev N, Gil C, Berthenet K, Bertolin G, Ichim G. Shedding light on mitochondrial outer-membrane permeabilization and membrane potential: state of the art methods and biosensors. Semin Cell Dev Biol. 2024;156:58\u201365. https:\/\/doi.org\/10.1016\/j.semcdb.2023.07.003.","journal-title":"Semin Cell Dev Biol"},{"key":"3461_CR46","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.bbrc.2020.10.083","volume":"534","author":"Y Li","year":"2021","unstructured":"Li Y, Xia J, Shao F, Zhou Y, Yu J, Wu H, et al. Sorafenib induces mitochondrial dysfunction and exhibits synergistic effect with cysteine depletion by promoting HCC cells ferroptosis. Biochem Biophys Res Commun. 2021;534:877\u201384.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"3461_CR47","doi-asserted-by":"publisher","first-page":"867","DOI":"10.31557\/APJCP.2022.23.3.867","volume":"23","author":"R Abolghasemi","year":"2022","unstructured":"Abolghasemi R, Ebrahimi-Barough S, Bahrami N, Ai J. Atorvastatin inhibits viability and migration of MCF7 breast cancer cells. Asian Pac J Cancer Prev. 2022;23(3):867\u201375. https:\/\/doi.org\/10.31557\/APJCP.2022.23.3.867.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"35","key":"3461_CR48","doi-asserted-by":"publisher","first-page":"37066","DOI":"10.18632\/oncotarget.5797","volume":"6","author":"P Kharaziha","year":"2015","unstructured":"Kharaziha P, Chioureas D, Baltatzis G, Fonseca P, Rodriguez P, Gogvadze V, et al. Sorafenib-induced defective autophagy promotes cell death by necroptosis. Oncotarget. 2015;6(35):37066\u201382. https:\/\/doi.org\/10.18632\/oncotarget.5797.","journal-title":"Oncotarget"},{"key":"3461_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1134758","volume":"14","author":"P Chittineedi","year":"2023","unstructured":"Chittineedi P, Mohammed A, Abdul Razab MKA, Mat Nawi N, Pandrangi SL. Polyherbal formulation conjugated to gold nanoparticles induced ferroptosis in drug-resistant breast cancer stem cells through ferritin degradation. Front Pharmacol. 2023;14:1134758. https:\/\/doi.org\/10.3389\/fphar.2023.1134758.","journal-title":"Front Pharmacol"},{"issue":"3","key":"3461_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/cimb47030201","volume":"47","author":"L Wang","year":"2025","unstructured":"Wang L, He X, Shen Y, Chen J, Chen Y, Zhou Z, et al. A novel ferroptosis-related gene prognosis signature and identifying atorvastatin as a potential therapeutic agent for hepatocellular carcinoma. Curr Opin Microbiol. 2025;47(3):201. https:\/\/doi.org\/10.3390\/cimb47030201.","journal-title":"Curr Opin Microbiol"},{"issue":"1","key":"3461_CR51","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1158\/1535-7163.MCT-10-0544","volume":"10","author":"T Nagai","year":"2011","unstructured":"Nagai T, Arao T, Furuta K, Sakai K, Kudo K, Kaneda H, et al. Sorafenib inhibits the Hepatocyte Growth Factor\u2013mediated epithelial mesenchymal transition in hepatocellular carcinoma. Mol Cancer Ther. 2011;10(1):169\u201377. https:\/\/doi.org\/10.1158\/1535-7163.MCT-10-0544.","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"3461_CR52","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nprot.2006.466","volume":"2","author":"A Albini","year":"2007","unstructured":"Albini A, Benelli R. The chemoinvasion assay: a method to assess tumor and endothelial cell invasion and its modulation. Nat Protoc. 2007;2(3):504\u201311. https:\/\/doi.org\/10.1038\/nprot.2006.466.","journal-title":"Nat Protoc"},{"issue":"1","key":"3461_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-03126-y","volume":"23","author":"CY Luo","year":"2023","unstructured":"Luo CY, Su WC, Jiang HF, Luo LT, Shen DY, Su GQ. DPY30 promotes colorectal carcinoma metastasis by upregulating ZEB1 transcriptional expression. Cancer Cell Int. 2023;23(1):333. https:\/\/doi.org\/10.1186\/s12935-023-03126-y.","journal-title":"Cancer Cell Int"},{"key":"3461_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcis.2025.139011","volume":"703","author":"C Fan","year":"2026","unstructured":"Fan C, Mei Y, Liu H, Chen L, Li Z, Wu K, et al. Sorafenib (SOR)\/simvastatin (SIM) dual-drug self-assembled nanoparticles for synergistic induction of tumor ferroptosis. J Colloid Interface Sci. 2026;703:139011. https:\/\/doi.org\/10.1016\/j.jcis.2025.139011.","journal-title":"J Colloid Interface Sci"},{"issue":"11","key":"3461_CR55","first-page":"401","volume":"6","author":"R Panonnummal","year":"2014","unstructured":"Panonnummal R, Varkey J. Statins induced nephrotoxicity: a dose dependent study in albino rats. Int J Pharm PharmSci. 2014Nov 1;6(11):401\u20136.","journal-title":"Int J Pharm PharmSci."},{"issue":"09","key":"3461_CR56","doi-asserted-by":"publisher","first-page":"464","DOI":"10.36348\/sjm.2025.v10i09.003","volume":"10","author":"AO Adefisan-Adeoye","year":"2025","unstructured":"Adefisan-Adeoye AO, Odewale MO, Adaramoye OA. Haematological and biochemical changes in Sorafenib-induced renal toxicity. Saudi J Med Med Sci. 2025;10(09):464\u201373. https:\/\/doi.org\/10.36348\/sjm.2025.v10i09.003.","journal-title":"Saudi J Med Med Sci"},{"issue":"6","key":"3461_CR57","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1681\/ASN.2013040387","volume":"25","author":"I Garcia-Gomez","year":"2014","unstructured":"Garcia-Gomez I, Pancholi N, Patel J, Gudehithlu KP, Sethupathi P, Hart P, et al. Activated omentum slows progression of CKD. J Am Soc Nephrol. 2014;25(6):1270\u201381. https:\/\/doi.org\/10.1681\/ASN.2013040387.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"3461_CR58","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.toxlet.2011.10.023","volume":"208","author":"ST Ahmad","year":"2012","unstructured":"Ahmad ST, Arjumand W, Nafees S, Seth A, Ali N, Rashid S, et al. Hesperidin alleviates acetaminophen induced toxicity in Wistar rats by abrogation of oxidative stress, apoptosis and inflammation. Toxicol Lett. 2012;208(2):149\u201361. https:\/\/doi.org\/10.1016\/j.toxlet.2011.10.023.","journal-title":"Toxicol Lett"},{"issue":"5","key":"3461_CR59","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1159\/000430165","volume":"36","author":"E Hochhauser","year":"2015","unstructured":"Hochhauser E, Lahat E, Sultan M, Pappo O, Waldman M, Sarne Y, et al. Ultra low dose Delta 9-Tetrahydrocannabinol protects mouse liver from ischemia reperfusion injury. Cell Physiol Biochem. 2015;36(5):1971\u201381. https:\/\/doi.org\/10.1159\/000430165.","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"3461_CR60","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3390\/livers3020022","volume":"3","author":"MR McGill","year":"2023","unstructured":"McGill MR, Kaufmann Y, LoBianco FV, Schleiff MA, Aykin-Burns N, Miller GP. The role of Cytochrome P450 3A4-mediated metabolism in Sorafenib and Lapatinib hepatotoxicity. Livers. 2023;3(2):310\u201321. https:\/\/doi.org\/10.3390\/livers3020022.","journal-title":"Livers"},{"key":"3461_CR61","doi-asserted-by":"publisher","first-page":"6165","DOI":"10.12659\/MSM.915790","volume":"25","author":"H Zeng","year":"2019","unstructured":"Zeng H, Liu Z. Atorvastatin induces hepatotoxicity in diabetic rats via oxidative stress, inflammation, and anti-apoptotic pathway. Med Sci Monit. 2019;25:6165\u201373. https:\/\/doi.org\/10.12659\/MSM.915790.","journal-title":"Med Sci Monit"},{"issue":"2","key":"3461_CR62","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/bcpt.13318","volume":"126","author":"W Ma","year":"2020","unstructured":"Ma W, Liu M, Liang F, Zhao L, Gao C, Jiang X, et al. Cardiotoxicity of Sorafenib is mediated through elevation of ROS level and CaMKII activity and dysregulation of calcium homoeostasis. Basic Clin Pharmacol Toxicol. 2020;126(2):166\u201380. https:\/\/doi.org\/10.1111\/bcpt.13318.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"3461_CR63","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.toxrep.2019.05.006","volume":"6","author":"J Fang","year":"2019","unstructured":"Fang J, Xu X, Jiang L, Qiao J, Zhou H, Li K. Preliminary results of toxicity studies in rats following low-dose and short-term exposure to Methyl mercaptan. Toxicol Rep. 2019;6:431\u20138. https:\/\/doi.org\/10.1016\/j.toxrep.2019.05.006.","journal-title":"Toxicol Rep"},{"key":"3461_CR64","unstructured":"Istr\u0103toaie O, Ofi\u0162eru AM, Nicola GC, et al. Myocardial interstitial fibrosis - histological and immunohistochemical aspects. Romanian Journal of Morphology and Embryology = Revue Roumaine de Morphologie et Embryologie. 2015\n;56(4):1473-1480. PMID: 26743297."},{"issue":"1","key":"3461_CR65","doi-asserted-by":"publisher","first-page":"32","DOI":"10.38150\/sajeb.5(1).p32-40","volume":"5","author":"SG Kamat","year":"2015","unstructured":"Kamat SG, Roy R. Evaluation of fish oils in amelioration of diabetes-induced tissue dam-ages in mice (Mus musculus). SAJEB. 2015;5(1):32\u201340. https:\/\/doi.org\/10.38150\/sajeb.5(1).p32-40.","journal-title":"SAJEB"},{"issue":"4","key":"3461_CR66","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1159\/000341465","volume":"30","author":"A Lupescu","year":"2012","unstructured":"Lupescu A, Shaik N, Jilani K, Zelenak C, Lang E, Pasham V, et al. Enhanced erythrocyte membrane exposure of phosphatidylserine following Sorafenib treatment: an in vivo and in vitro study. Cell Physiol Biochem. 2012;30(4):876\u201388. https:\/\/doi.org\/10.1159\/000341465.","journal-title":"Cell Physiol Biochem"},{"issue":"3","key":"3461_CR67","doi-asserted-by":"publisher","DOI":"10.1177\/1559325819869076","volume":"17","author":"RB Rana","year":"2019","unstructured":"Rana RB, Jilani K, Shahid M, Riaz M, Ranjha MH, Bibi I, et al. Atorvastatin induced erythrocytes membrane blebbing. Dose Response. 2019;17(3):155932581986907. https:\/\/doi.org\/10.1177\/1559325819869076.","journal-title":"Dose Response"},{"issue":"6","key":"3461_CR68","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.3892\/or.2014.3497","volume":"32","author":"EH Kim","year":"2014","unstructured":"Kim EH, Kim MS, Jung WG. The mechanisms responsible for the radiosensitizing effects of Sorafenib on colon cancer cells. Oncol Rep. 2014;32(6):2421\u20132128. https:\/\/doi.org\/10.3892\/or.2014.3497.","journal-title":"Oncol Rep"},{"issue":"1","key":"3461_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1186-0","volume":"15","author":"M Broecker-Preuss","year":"2015","unstructured":"Broecker-Preuss M, M\u00fcller S, Britten M, Worm K, Schmid KW, Mann K, et al. Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status. BMC Cancer. 2015;15(1):184. https:\/\/doi.org\/10.1186\/s12885-015-1186-0.","journal-title":"BMC Cancer"},{"issue":"6","key":"3461_CR70","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1158\/0008-5472.CAN-10-3367","volume":"71","author":"Z Cao","year":"2011","unstructured":"Cao Z, Fan-Minogue H, Bellovin DI, Yevtodiyenko A, Arzeno J, Yang Q, et al. MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductase. Cancer Res. 2011;71(6):2286\u201397. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-3367.","journal-title":"Cancer Res"},{"issue":"6","key":"3461_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/biology13060455","volume":"13","author":"G Glebavi\u010di\u016bt\u0117","year":"2024","unstructured":"Glebavi\u010di\u016bt\u0117 G, Vijaya AK, Preta G. Effect of statin lipophilicity on the proliferation of hepatocellular carcinoma cells. Biology. 2024;13(6):455. https:\/\/doi.org\/10.3390\/biology13060455.","journal-title":"Biology"},{"issue":"2","key":"3461_CR72","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2022.13186","volume":"23","author":"P Xu","year":"2022","unstructured":"Xu P, Wang Y, Deng Z, Tan Z, Pei X. MicroRNA\u201115a promotes prostate cancer cell ferroptosis by inhibiting GPX4 expression. Oncol Lett. 2022;23(2):67. https:\/\/doi.org\/10.3892\/ol.2022.13186.","journal-title":"Oncol Lett"},{"issue":"10","key":"3461_CR73","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.18632\/aging.101974","volume":"11","author":"F Bai","year":"2019","unstructured":"Bai F, Yu Z, Gao X, Gong J, Fan L, Liu F. Simvastatin induces breast cancer cell death through oxidative stress up-regulating miR-140-5p. Aging (Albany NY). 2019;11(10):3198\u2013219. https:\/\/doi.org\/10.18632\/aging.101974.","journal-title":"Aging (Albany NY)"},{"key":"3461_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.806081","volume":"10","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Qu H, Chen Y, Luo X, Chen C, Xiao B, et al. Atorvastatin induces mitochondria-dependent ferroptosis via the modulation of Nrf2-xCT\/GPx4 axis. Front Cell Dev Biol. 2022;10:806081. https:\/\/doi.org\/10.3389\/fcell.2022.806081.","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"3461_CR75","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1016\/j.ymthe.2021.03.022","volume":"29","author":"H Wang","year":"2021","unstructured":"Wang H, Cheng Y, Mao C, Liu S, Xiao D, Huang J, et al. Emerging mechanisms and targeted therapy of ferroptosis in cancer. Mol Ther. 2021;29(7):2185\u2013208. https:\/\/doi.org\/10.1016\/j.ymthe.2021.03.022.","journal-title":"Mol Ther"},{"key":"3461_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118782","volume":"572","author":"H Tang","year":"2019","unstructured":"Tang H, Chen D, Li C, Zheng C, Wu X, Zhang Y, et al. Dual GSH-exhausting sorafenib loaded manganese-silica nanodrugs for inducing the ferroptosis of hepatocellular carcinoma cells. Int J Pharm. 2019;572:118782. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118782.","journal-title":"Int J Pharm"},{"key":"3461_CR77","unstructured":"1-s2.0-S0167488916302324-main."},{"key":"3461_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/5080843","volume":"2019","author":"LJ Su","year":"2019","unstructured":"Su LJ, Zhang JH, Gomez H, Murugan R, Hong X, Xu D, et al. Reactive oxygen species-induced lipid peroxidation in apoptosis, autophagy, and ferroptosis. Oxid Med Cell Longev. 2019;2019:1\u201313. https:\/\/doi.org\/10.1155\/2019\/5080843.","journal-title":"Oxid Med Cell Longev"},{"issue":"10","key":"3461_CR79","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1158\/1535-7163.MCT-12-0093","volume":"11","author":"R Coriat","year":"2012","unstructured":"Coriat R, Nicco C, Ch\u00e9reau C, Mir O, Alexandre J, Ropert S, et al. Sorafenib-induced hepatocellular carcinoma cell death depends on reactive oxygen species production in vitro and in vivo. Mol Cancer Ther. 2012;11(10):2284\u201393. https:\/\/doi.org\/10.1158\/1535-7163.MCT-12-0093.","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"3461_CR80","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/bjc.2013.334","volume":"109","author":"J Wan","year":"2013","unstructured":"Wan J, Liu T, Mei L, Li J, Gong K, Yu C, et al. Synergistic antitumour activity of Sorafenib in combination with Tetrandrine is mediated by reactive oxygen species (ROS)\/Akt signaling. Br J Cancer. 2013;109(2):342\u201350. https:\/\/doi.org\/10.1038\/bjc.2013.334.","journal-title":"Br J Cancer"},{"key":"3461_CR81","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.lfs.2016.04.018","volume":"153","author":"B Buranrat","year":"2016","unstructured":"Buranrat B, Senggunprai L, Prawan A, Kukongviriyapan V. Simvastatin and Atorvastatin as inhibitors of proliferation and inducers of apoptosis in human cholangiocarcinoma cells. Life Sci. 2016;153:41\u20139. https:\/\/doi.org\/10.1016\/j.lfs.2016.04.018.","journal-title":"Life Sci"},{"key":"3461_CR82","doi-asserted-by":"publisher","unstructured":"Al Hassan M, Reda F, Baltaji A, Usta J, Borjac J. Effect of sorafenib on human colon cancer cells. BAU Journal - Health and Wellbeing. 2021 Apr 30;3(2). https:\/\/doi.org\/10.54729\/2789-8288.1132.","DOI":"10.54729\/2789-8288.1132"},{"key":"3461_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00463","volume":"30","author":"HA Omar","year":"2016","unstructured":"Omar HA, Tolba MF, Hung JH, Al-Tel TH. OSU-2S\/Sorafenib synergistic antitumor combination against hepatocellular carcinoma: The role of PKC\u03b4\/p53. Front Pharmacol. 2016;30:7. https:\/\/doi.org\/10.3389\/fphar.2016.00463.","journal-title":"Front Pharmacol"},{"issue":"1","key":"3461_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-79948-1","volume":"14","author":"I Druzhkova","year":"2024","unstructured":"Druzhkova I, Potapov A, Ignatova N, Bugrova M, Shchechkin I, Lukina M, et al. Cell hiding in colorectal cancer: correlation with response to chemotherapy in vitro and in vivo. Sci Rep. 2024;14(1):28762. https:\/\/doi.org\/10.1038\/s41598-024-79948-1.","journal-title":"Sci Rep"},{"issue":"1","key":"3461_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30481-7","volume":"13","author":"O Hassin","year":"2022","unstructured":"Hassin O, Nataraj NB, Shreberk-Shaked M, Aylon Y, Yaeger R, Fontemaggi G, et al. Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patients. Nat Commun. 2022;13(1):2800. https:\/\/doi.org\/10.1038\/s41467-022-30481-7.","journal-title":"Nat Commun"},{"issue":"4","key":"3461_CR86","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1002\/ijc.24766","volume":"126","author":"Z Yang","year":"2010","unstructured":"Yang Z, Xiao H, Jin H, Koo PT, Tsang DJ, Yang CS. Synergistic actions of Atorvastatin with \u03b3\u2010tocotrienol and Celecoxib against human colon cancer HT29 and HCT116 cells. Intl Journal of Cancer. 2010;126(4):852\u201363. https:\/\/doi.org\/10.1002\/ijc.24766.","journal-title":"Intl Journal of Cancer"},{"key":"3461_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.116112","volume":"171","author":"X Xu","year":"2024","unstructured":"Xu X, Xu XD, Ma MQ, Liang Y, Cai YB, Zhu ZX, et al. The mechanisms of ferroptosis and its role in atherosclerosis. Biomed Pharmacother. 2024;171:116112. https:\/\/doi.org\/10.1016\/j.biopha.2023.116112.","journal-title":"Biomed Pharmacother"},{"key":"3461_CR88","doi-asserted-by":"publisher","DOI":"10.1177\/2040622319862714","volume":"10","author":"A Zinellu","year":"2019","unstructured":"Zinellu A, Paliogiannis P, Usai MF, Carru C, Mangoni AA. Effect of statin treatment on circulating malondialdehyde concentrations: a systematic review and meta-analysis. Ther Adv Chronic Dis. 2019;10:2040622319862714. https:\/\/doi.org\/10.1177\/2040622319862714.","journal-title":"Ther Adv Chronic Dis"},{"key":"3461_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/7453406","volume":"2020","author":"AF AlAsmari","year":"2020","unstructured":"AlAsmari AF, Ali N, AlAsmari F, AlAnazi WA, Alqahtani F, Alharbi M, et al. Elucidation of the molecular mechanisms underlying Sorafenib-induced hepatotoxicity. Oxid Med Cell Longev. 2020;2020:1\u201310. https:\/\/doi.org\/10.1155\/2020\/7453406.","journal-title":"Oxid Med Cell Longev"},{"issue":"11","key":"3461_CR90","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10112890","volume":"10","author":"J St\u0119pniak","year":"2022","unstructured":"St\u0119pniak J, Krawczyk-Lipiec J, Lewi\u0144ski A, Karbownik-Lewi\u0144ska M. Sorafenib versus Lenvatinib causes stronger oxidative damage to membrane lipids in noncancerous tissues of the thyroid, liver, and kidney: effective protection by melatonin and indole-3-propionic acid. Biomedicines. 2022;10(11):2890. https:\/\/doi.org\/10.3390\/biomedicines10112890.","journal-title":"Biomedicines"},{"issue":"4","key":"3461_CR91","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2174\/0115748863267262231025052412","volume":"19","author":"S Mehrzadi","year":"2024","unstructured":"Mehrzadi S, Hosseini A, Hosseinzadeh A. Evaluating the protective effect of melatonin on Atorvastatin-inducedmitochondrial toxicity in pancreatic beta cells. CDS. 2024;19(4):455\u201364. https:\/\/doi.org\/10.2174\/0115748863267262231025052412.","journal-title":"CDS"},{"issue":"4","key":"3461_CR92","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.3892\/ijo.2014.2584","volume":"45","author":"KE Hwang","year":"2014","unstructured":"Hwang KE, Kim YS, Hwang YR, Kwon SJ, Park DS, Cha BK, et al. Enhanced apoptosis by Pemetrexed and Simvastatin in malignant mesothelioma and lung cancer cells by reactive oxygen species-dependent mitochondrial dysfunction and Bim induction. Int J Oncol. 2014;45(4):1769\u201377. https:\/\/doi.org\/10.3892\/ijo.2014.2584.","journal-title":"Int J Oncol"},{"issue":"1","key":"3461_CR93","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10549-013-2668-x","volume":"141","author":"C Fumarola","year":"2013","unstructured":"Fumarola C, Caffarra C, La Monica S, Galetti M, Alfieri RR, Cavazzoni A, et al. Effects of Sorafenib on energy metabolism in breast cancer cells: role of AMPK\u2013mTORC1 signaling. Breast Cancer Res Treat. 2013;141(1):67\u201378. https:\/\/doi.org\/10.1007\/s10549-013-2668-x.","journal-title":"Breast Cancer Res Treat"},{"key":"3461_CR94","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.925653","volume":"12","author":"JM Hu","year":"2022","unstructured":"Hu JM, Chang YL, Hsieh CC, Huang SM. The synergistic cytotoxic effects of GW5074 and Sorafenib by impacting mitochondrial functions in human colorectal cancer cell lines. Front Oncol. 2022;12:925653. https:\/\/doi.org\/10.3389\/fonc.2022.925653.","journal-title":"Front Oncol"},{"issue":"22","key":"3461_CR95","doi-asserted-by":"publisher","first-page":"18891","DOI":"10.18632\/oncotarget.3783","volume":"6","author":"YY Zaytseva","year":"2015","unstructured":"Zaytseva YY, Harris JW, Mitov MI, Kim JT, Butterfield DA, Lee EY, et al. Increased expression of fatty acid synthase provides a survival advantage to colorectal cancer cells via upregulation of cellular respiration. Oncotarget. 2015;6(22):18891\u2013904. https:\/\/doi.org\/10.18632\/oncotarget.3783.","journal-title":"Oncotarget"},{"issue":"2","key":"3461_CR96","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/jcsm.12654","volume":"12","author":"H Mollazadeh","year":"2021","unstructured":"Mollazadeh H, Tavana E, Fanni G, Bo S, Banach M, Pirro M, et al. Effects of statins on mitochondrial pathways. J Cachexia Sarcopenia Muscle. 2021;12(2):237\u201351. https:\/\/doi.org\/10.1002\/jcsm.12654.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"10","key":"3461_CR97","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1002\/jat.3825","volume":"39","author":"L Li","year":"2019","unstructured":"Li L, Zhao Z, Zhang L, He J, Zhang T, Guo J, et al. Atorvastatin induces mitochondrial dysfunction and cell apoptosis in HepG2 cells via inhibition of the Nrf2 pathway. J Appl Toxicol. 2019;39(10):1394\u2013404. https:\/\/doi.org\/10.1002\/jat.3825.","journal-title":"J Appl Toxicol"},{"issue":"1","key":"3461_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-57707-2","volume":"10","author":"A Otahal","year":"2020","unstructured":"Otahal A, Aydemir D, Tomasich E, Minichsdorfer C. Delineation of cell death mechanisms induced by synergistic effects of statins and erlotinib in non-small cell lung cancer cell (NSCLC) lines. Sci Rep. 2020;10(1):959. https:\/\/doi.org\/10.1038\/s41598-020-57707-2.","journal-title":"Sci Rep"},{"issue":"1","key":"3461_CR99","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41852-z","volume":"14","author":"Z Ding","year":"2023","unstructured":"Ding Z, Pan Y, Shang T, Jiang T, Lin Y, Yang C, et al. URI alleviates tyrosine kinase inhibitors-induced ferroptosis by reprogramming lipid metabolism in p53 wild-type liver cancers. Nat Commun. 2023;14(1):6269. https:\/\/doi.org\/10.1038\/s41467-023-41852-z.","journal-title":"Nat Commun"},{"issue":"1","key":"3461_CR100","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/19336918.2017.1288789","volume":"12","author":"CC Cheng","year":"2018","unstructured":"Cheng CC, Chao WT, Liao CC, Tseng YH, Lai YCC, Lai YS, et al. Plectin deficiency in liver cancer cells promotes cell migration and sensitivity to sorafenib treatment. Cell Adhes Migr. 2018;12(1):19\u201327. https:\/\/doi.org\/10.1080\/19336918.2017.1288789.","journal-title":"Cell Adhes Migr"},{"key":"3461_CR101","unstructured":"Ha TY, Hwang S, Moon KM, Won YJ, Song GW, Kim N, Tak E, Ryoo BY, Hong HN. Sorafenib inhibits migration and invasion of hepatocellular carcinoma cells through suppression of matrix metalloproteinase expression. Anticancer research. 2015 Apr 1;35(4):1967-76."},{"issue":"7","key":"3461_CR102","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1159\/000505521","volume":"98","author":"S Dattachoudhury","year":"2020","unstructured":"Dattachoudhury S, Sharma R, Kumar A, Jaganathan BG. Sorafenib inhibits proliferation, migration and invasion of breast cancer cells. Oncology. 2020;98(7):478\u201386. https:\/\/doi.org\/10.1159\/000505521.","journal-title":"Oncology"},{"key":"3461_CR103","unstructured":"Jones HM, Fang Z, Sun W, Clark LH, Stine JE, Tran AQ, Sullivan SA, Gilliam TP, Zhou C, Bae-Jump VL. Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer in vitro. Am J Cancer Res. 2017 Dec 1;7(12):2478-2490. Erratum in: Am J Cancer Res. 2018 May 01;8(5):915. PMID: 29312801; PMCID: PMC5752688."},{"key":"3461_CR104","doi-asserted-by":"publisher","unstructured":"Redza-Dutordoir M, Averill-Bates DA. Activation of apoptosis signalling pathways by reactive oxygen species. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research. 2016 Dec 1;1863(12):2977-92.\u00a0https:\/\/doi.org\/10.1016\/j.bbamcr.2016.09.012.","DOI":"10.1016\/j.bbamcr.2016.09.012"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03461-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03461-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03461-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:04:08Z","timestamp":1790276648000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03461-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":104,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["3461"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03461-z","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"1 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known financial or personal interests that could have influenced the scientific work presented in this manuscript in any way.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"221"}}